4.8 Review

Delirium in elderly people

Journal

LANCET
Volume 383, Issue 9920, Pages 911-922

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(13)60688-1

Keywords

-

Funding

  1. National Institute on Aging [P01AG031720]
  2. Milton and Shirley F Levy Family Chair
  3. Leyden Academy on Vitality and Ageing
  4. US National Institutes of Health [K01AG033643, U01HL10526]

Ask authors/readers for more resources

Delirium is an acute disorder of attention and cognition in elderly people (ie, those aged 65 years or older) that is common, serious, costly, under-recognised, and often fatal. A formal cognitive assessment and history of acute onset of symptoms are necessary for diagnosis. In view of the complex multifactorial causes of delirium, multicomponent non-pharmacological risk factor approaches are the most effective strategy for prevention. No convincing evidence shows that pharmacological prevention or treatment is effective. Drug reduction for sedation and analgesia and non-pharmacological approaches are recommended. Delirium offers opportunities to elucidate brain pathophysiology-it serves both as a marker of brain vulnerability with decreased reserve and as a potential mechanism for permanent cognitive damage. As a potent indicator of patients' safety, delirium provides a target for system-wide process improvements. Public health priorities include improvements in coding, reimbursement from insurers, and research funding, and widespread education for clinicians and the public about the importance of delirium.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available